Cardiometabolic Rare Disease Specialty Rep — RNAi Launch
Listed on 2026-10-11
-
Sales
-
Pharmaceutical
Scorpion Therapeutics is seeking a Specialty Sales Representative to launch and expand RNAi therapies in cardiometabolic diseases, including Plozasiran for rare cardiovascular conditions. The role focuses on data-driven territory planning, prescriber activation, and building strong healthcare professional relationships.
You will navigate complex healthcare systems, collaborate across teams to drive product adoption, and support market penetration with an emphasis on rare, high-need populations.
Consider building your career as a Cardiometabolic Rare Disease Specialty Rep — RNAi Launch at Arrowhead Pharmaceuticals, Inc.
This role, Cardiometabolic Rare Disease Specialty Rep — RNAi Launch at Arrowhead Pharmaceuticals, Inc., could be your next career step.
Are you ready to take on the Cardiometabolic Rare Disease Specialty Rep — RNAi Launch role at Arrowhead Pharmaceuticals, Inc.?
We would love to welcome a new Cardiometabolic Rare Disease Specialty Rep — RNAi Launch to our team in Hattiesburg, MS, United States.
(If this job is in fact in your jurisdiction, then you may be using a Proxy or VPN to access this site, and to progress further, you should change your connectivity to another mobile device or PC).